|
LNPEP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.352900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.151690E-04 |
| Normal-vs-Stage2 |
2.390000E-02 |
| Normal-vs-Stage3 |
3.645200E-01 |
| Normal-vs-Stage4 |
1.262390E-01 |
| Stage1-vs-Stage2 |
6.718600E-01 |
| Stage1-vs-Stage3 |
2.592600E-01 |
| Stage1-vs-Stage4 |
9.136600E-01 |
| Stage2-vs-Stage3 |
4.976200E-01 |
| Stage2-vs-Stage4 |
8.582600E-01 |
| Stage3-vs-Stage4 |
5.503600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.956500E-04 |
| Normal-vs-AfricanAmerican |
2.236300E-03 |
| Normal-vs-Asian |
6.443500E-03 |
| Caucasian-vs-AfricanAmerican |
8.328000E-01 |
| Caucasian-vs-Asian |
5.352800E-01 |
| AfricanAmerican-vs-Asian |
5.129200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21769999999566E-05 |
| Normal-vs-Female |
7.520200E-01 |
| Male-vs-Female |
7.999600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.862450E-03 |
| Normal-vs-Extreme_Weight |
1.58475999999519E-05 |
| Normal-vs-Obese |
5.985600E-02 |
| Normal-vs-Extreme_Obese |
7.043400E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.106200E-01 |
| Normal_Weight-vs-Obese |
2.155000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.673600E-01 |
| Extreme_Weight-vs-Obese |
3.306100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.300200E-01 |
| Obese-vs-Extreme_Obese |
5.683900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.032400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.166400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.71820000017098E-07 |
| Normal-vs-Age(81-100Yrs) |
2.28769999610634E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.876800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.803430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.248400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.184700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.9258000000042E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.958160E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.99489999999481E-05 |
| Normal-VS-Type2 PRCC |
1.649780E-04 |
| Normal-VS-KIRP CIMP |
4.446400E-01 |
| Normal-VS-Unclassified PRCC |
8.993600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.148800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.359900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.352400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.061790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.850300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.566000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97155999999143E-05 |
| Normal-vs-N1 |
4.186400E-01 |
| Normal-vs-N2 |
1.700620E-01 |
| N0-vs-N1 |
1.266050E-01 |
| N0-vs-N2 |
6.317400E-01 |
| N1-vs-N2 |
7.063200E-01 |
|
|
